US 4,156,089 AGrant
.Omega.-Aryl-13,14-Didehydro-Interphenylene-PGF Compounds
Issue Date:1979-05-22
•36 Claims
Abstract
This invention comprises certain analogs of the prostagladins in which the double bond between C-13 and C-14 is replaced by a triple bond. Also provided in this invention, are novel chemical processes and novel chemical intermediates useful in the preparation of the above prostaglandin analogs. These prostaglandin analogs exhibit prostaglandin-like activity, and are accordingly useful for the same pharmacological purposes as the prostaglandins. Among these purposes are blood pressure lowering, labor induction at term, reproductive-cycle regulation, gastric antisecretory action, and the like.
Metadata
Assignee
- The Upjohn Company
Inventor
- Herman W. Smith
Application Information
Application Number:US 9008403
Filing Date:1978-04-28
Priority Date:1976-02-13
Art Unit:126
Classifications
IPC:
C07C11700
Field of Search:
56056255;53465
Patent Drawings
This patent does not have any drawings.
Description
The present invention relates to prostaglandin analogs, for which the essential material constituting disclosure therefor is incorporated by reference here from Ser. No. 657,739, filed Feb. 13, 1976, now issued as U.S. Pat. No. 4,029,681.
Claims
I claim:
1. A prostaglandin analog of the formula: ##STR1## WHEREIN D is ##STR2## wherein Y.sub.1 is --C.tbd.C--; wherein Z.sub.5 is ##STR3## WHEREIN G IS ONE, 2, OR 3; WHEREIN Z.sub.3 is oxa or methylene; Wherein T is chloro; fluoro, trifluoromethyl, alkyl of one to 3 carbon atoms, inclusive, or alkoxy of one to 3 carbon atoms, inclusive, and s is zero, one, 2, or 3, the various T's being the same or different, with the proviso that not more than two T's are other than alkyl; Wherein M.sub.1 is ##STR4## wherein R.sub.5 and R.sub.6 are hydrogen or methyl, with the proviso that one of R.sub.5 and R.sub.6 is methyl only when the other is hydrogen; Wherein L.sub.1 is ##STR5## or a mixture of ##STR6## wherein R.sub.3 and R.sub.4 are hydrogen, methyl, or fluoro, being the same or different, with the proviso that one of R.sub.3 and R.sub.4 is fluoro only when the other is hydrogen or fluoro and Z.sub.3 is methylene; and Wherein R.sub.1 is hydrogen, alkyl of one to 12 carbon atoms, inclusive, cycloalkyl of 3 to 10 carbon atoms, inclusive, aralkyl of 7 to 12 carbon atoms, inclusive, phenyl, phenyl substituted with one, two, or three chloro or alkyl of one to 3 carbon atoms, inclusive, or a pharmacologically acceptable cation.
2. A compound according to claim 1 wherein D is ##STR7##
3. A compound according to claim 1 wherein D is ##STR8##
4. A compound according to claim 3 wherein Z.sub.3 is methylene.
5. A compound according to claim 4 wherein s is zero or one and T is chloro, fluoro, or trifluoromethyl.
6. A compound according to claim 3 wherein Z.sub.3 is oxa.
7. A compound according to claim 6 wherein s is zero.
8. A compound according to claim 6 wherein s is zero or one and T is chloro, fluoro, or trifluoromethyl.
9. A compound according to claim 8 wherein Z.sub.1 is ##STR9##
10. A compound according to claim 8 wherein Z.sub.1 is ##STR10##
11. A compound according to claim 8 wherein M.sub.1 is ##STR11##
12. A compound according to claim 11 wherein g is one.
13. A compound according to claim 12 wherein R.sub.3, R.sub.4, R.sub.5, and R.sub.6 are all hydrogen.
14. 15-epi-3,7-Inter-m-phe nylene-3-oxa-4,5,6,17,18,19,20-heptanor-13,14-didehydro-PGF.sub.1.alpha., methyl ester, a compound according to claim 13.
15. A compound according to claim 13, wherein M.sub.1 is ##STR12##
16. A compound according to claim 15, wherein g is three.
17. A compound according to claim 15, wherein g is one.
18. A compound according to claim 17, wherein R.sub.3 and R.sub.4 are both hydrogen.
19. A compound according to claim 18 wherein R.sub.5 is methyl.
20. 3,7-Inter-m-phenylene-3-oxa-4,5,6,17,18,19,20-heptanor-16-p henoxy-15-methyl-13,14-didehydro-PGF.sub.1.alpha., a compound according to claim 19.
21. 3,7-In ter-m-phenylene-3-oxa-4,5,6,17,18,19,20-heptanor-16-phenoxy-15-methyl-13,14 -didehydro-PGF.sub.1.alpha., methyl ester, a compound according to claim 19.
22. A compound according to claim 18 wherein R.sub.6 is methyl.
23. 3,7-Inter-m-phenylene-3-oxa-4,5,6,17,18,19,20-heptanor-16-p henoxy-13,14-didehydro-PGF.sub.1.alpha., 15-methyl ether, a compound according to claim 22.
24. 3,7-Inter-m-phenyle ne-3-oxa-4,5,6,17,18,19,20-heptanor-16-phenoxy-13,14-didehydro-PGF.sub.1.al pha., methyl ester, 15-methyl ether, a compound according to claim 22.
25. A compound according to claim 18, wherein R.sub.5 and R.sub.6 are both hydrogen.
26. 3,7-In ter-m-phenylene-3-oxa-4,5,6,17,18,19,20-heptanor-16-phenoxy-13,14-didehydro -PGF.sub.1.alpha., a compound according to claim 25.
27. 3,7-Inter-m-phenylene-3-oxa-4,5,6,17,18,19,20-he ptanor-16-phenoxy-13,14-didehydro-PGF.sub.1.alpha., methyl ester, a compound according to claim 25.
28. A compound according to claim 17, wherein at least one of R.sub.3 and R.sub.4 is methyl.
29. A compound according to claim 28, wherein R.sub.3 and R.sub.4 are both methyl.
30. A compound according to claim 29, wherein R.sub.5 is methyl.
31. 3,7-Inter-m-phenylene-3-oxa-4,5,6,18,19,20-hexanor-16-phenox y-15,16-dimethyl-13,14-didehydro-PGF.sub.1.alpha., methyl ester, a compound according to claim 30.
32. A compound according to claim 29, wherein R.sub.6 is methyl.
33. 3,7-Inter-m-phenylene-3-oxa-4,5,6,18,19,20-hexanor-16-phenox y-16-methyl-13,14-didehydro-PGF.sub.1.alpha., methyl ester, 15-methyl ether, a compound according to claim 32.
34. A compound according to claim 29, wherein R.sub.5 and R.sub.6 are both hydrogen.
35. 3,7-In ter-m-phenylene-3-oxa-4,5,6,18,19,20-hexanor-16-phenoxy-16-methyl-13,14-did ehydro-PGF.sub.1.alpha., a compound according to claim 34.
36. 3,7-Inter-m-phenylene-3-oxa-4,5,6,18,19,20-hexanor-16- phenoxy-16-methyl-13,14-didehydro-PGF.sub.1.alpha., methyl ester, a compound according to claim 34.